137 related articles for article (PubMed ID: 35288151)
1. Ruthenium(II) carbon monoxide releasing molecules: Structural perspective, antimicrobial and anti-inflammatory properties.
Mansour AM; Khaled RM; Khaled E; Ahmed SK; Ismael OS; Zeinhom A; Magdy H; Ibrahim SS; Abdelfatah M
Biochem Pharmacol; 2022 May; 199():114991. PubMed ID: 35288151
[TBL] [Abstract][Full Text] [Related]
2. A thiol-reactive Ru(II) ion, not CO release, underlies the potent antimicrobial and cytotoxic properties of CO-releasing molecule-3.
Southam HM; Smith TW; Lyon RL; Liao C; Trevitt CR; Middlemiss LA; Cox FL; Chapman JA; El-Khamisy SF; Hippler M; Williamson MP; Henderson PJF; Poole RK
Redox Biol; 2018 Sep; 18():114-123. PubMed ID: 30007887
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics of
Carvalho SM; Marques J; Romão CC; Saraiva LM
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332064
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome bd-I in Escherichia coli is less sensitive than cytochromes bd-II or bo'' to inhibition by the carbon monoxide-releasing molecule, CORM-3: N-acetylcysteine reduces CO-RM uptake and inhibition of respiration.
Jesse HE; Nye TL; McLean S; Green J; Mann BE; Poole RK
Biochim Biophys Acta; 2013 Sep; 1834(9):1693-703. PubMed ID: 23624261
[TBL] [Abstract][Full Text] [Related]
5. Carbon monoxide-releasing antibacterial molecules target respiration and global transcriptional regulators.
Davidge KS; Sanguinetti G; Yee CH; Cox AG; McLeod CW; Monk CE; Mann BE; Motterlini R; Poole RK
J Biol Chem; 2009 Feb; 284(7):4516-24. PubMed ID: 19091747
[TBL] [Abstract][Full Text] [Related]
6. Development of Triggerable, Trackable, and Targetable Carbon Monoxide Releasing Molecules.
Lazarus LS; Benninghoff AD; Berreau LM
Acc Chem Res; 2020 Oct; 53(10):2273-2285. PubMed ID: 32929957
[TBL] [Abstract][Full Text] [Related]
7. Ruthenium, Not Carbon Monoxide, Inhibits the Procoagulant Activity of
Nielsen VG
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340168
[TBL] [Abstract][Full Text] [Related]
8. The carbon monoxide-releasing molecule CORM-2 inhibits the inflammatory response induced by cytokines in Caco-2 cells.
Megías J; Busserolles J; Alcaraz MJ
Br J Pharmacol; 2007 Apr; 150(8):977-86. PubMed ID: 17339836
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic applications of carbon monoxide-releasing molecules.
Motterlini R; Mann BE; Foresti R
Expert Opin Investig Drugs; 2005 Nov; 14(11):1305-18. PubMed ID: 16255672
[TBL] [Abstract][Full Text] [Related]
10. Carbon monoxide-releasing molecules modulate leukocyte-endothelial interactions under flow.
Urquhart P; Rosignoli G; Cooper D; Motterlini R; Perretti M
J Pharmacol Exp Ther; 2007 May; 321(2):656-62. PubMed ID: 17289832
[TBL] [Abstract][Full Text] [Related]
11. A carbon monoxide-releasing molecule (CORM-3) attenuates lipopolysaccharide- and interferon-gamma-induced inflammation in microglia.
Bani-Hani MG; Greenstein D; Mann BE; Green CJ; Motterlini R
Pharmacol Rep; 2006; 58 Suppl():132-44. PubMed ID: 17332683
[TBL] [Abstract][Full Text] [Related]
12. Interaction of the carbon monoxide-releasing molecule Ru(CO)3Cl(glycinate) (CORM-3) with Salmonella enterica serovar Typhimurium: in situ measurements of carbon monoxide binding by integrating cavity dual-beam spectrophotometry.
Rana N; McLean S; Mann BE; Poole RK
Microbiology (Reading); 2014 Dec; 160(Pt 12):2771-2779. PubMed ID: 25085864
[TBL] [Abstract][Full Text] [Related]
13. Differential antibacterial activity against Pseudomonas aeruginosa by carbon monoxide-releasing molecules.
Desmard M; Foresti R; Morin D; Dagouassat M; Berdeaux A; Denamur E; Crook SH; Mann BE; Scapens D; Montravers P; Boczkowski J; Motterlini R
Antioxid Redox Signal; 2012 Jan; 16(2):153-63. PubMed ID: 21864022
[TBL] [Abstract][Full Text] [Related]
14. Carbon monoxide liberated from carbon monoxide-releasing molecule CORM-2 attenuates inflammation in the liver of septic mice.
Cepinskas G; Katada K; Bihari A; Potter RF
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G184-91. PubMed ID: 17991708
[TBL] [Abstract][Full Text] [Related]
15. Ru(CO)3Cl(Glycinate) (CORM-3): a carbon monoxide-releasing molecule with broad-spectrum antimicrobial and photosensitive activities against respiration and cation transport in Escherichia coli.
Wilson JL; Jesse HE; Hughes B; Lund V; Naylor K; Davidge KS; Cook GM; Mann BE; Poole RK
Antioxid Redox Signal; 2013 Aug; 19(5):497-509. PubMed ID: 23186316
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule.
Clark JE; Naughton P; Shurey S; Green CJ; Johnson TR; Mann BE; Foresti R; Motterlini R
Circ Res; 2003 Jul; 93(2):e2-8. PubMed ID: 12842916
[TBL] [Abstract][Full Text] [Related]
17. Interaction of carbon monoxide-releasing ruthenium carbonyl CORM-3 with plasma fibronectin.
Aki T; Unuma K; Noritake K; Kurahashi H; Funakoshi T; Uemura K
Toxicol In Vitro; 2018 Aug; 50():201-209. PubMed ID: 29580987
[TBL] [Abstract][Full Text] [Related]
18. The anticoagulant effect of Apis mellifera phospholipase A
Nielsen VG
J Thromb Thrombolysis; 2020 Jan; 49(1):100-107. PubMed ID: 31679116
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo effects of the carbon monoxide-releasing molecule, CORM-3, in the xenogeneic pig-to-primate context.
Vadori M; Seveso M; Besenzon F; Bosio E; Tognato E; Fante F; Boldrin M; Gavasso S; Ravarotto L; Mann BE; Simioni P; Ancona E; Motterlini R; Cozzi E
Xenotransplantation; 2009; 16(2):99-114. PubMed ID: 19392725
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances on Carbon Monoxide Releasing Molecules for Antibacterial Applications.
Cheng J; Hu J
ChemMedChem; 2021 Dec; 16(24):3628-3634. PubMed ID: 34613654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
